Compendia Bioscience was founded by Arul Chinnaiyan and Dan Rhodes in February 2006 with the goal of building a commercial version of Oncomine™ that would have a greater ability to impact drug development and clinical practice. Compendia licensed Oncomine and related technologies from the University of Michigan.